|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
- Mutatiile ADN-ului de radicalii liberi afecteaza energia celulara ATP Administrarea de antioxidanti ca factor anti cancer determina reversia fenotipului malign prin inhibarea celulelor de cancer - Anti cancer: EGCG Galatul de epigalocatechina
Neutralizarea de radicali liberi - Densitatea antioxidativa Despre antioxidanti: Antioxidantii sint molecule care apara
organismul de efectele oxigenului reactiv - Radicalii liberi
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Anticancer-Oncoxin cu Germaniu Organic (GE-132) in activitatea anticancer la activarea importanta de macrofage si celulele T.
| Antioxidantii apara celula de efectele oxigenului reactiv | Antioxidantii cu neutralizarea de radicali liberi - Capacitate scazuta antioxidativa |
 |
 |
- Antioxidanti se gasesc in orice celula, protejeaza organismul
de distrugerile provocate la nivel celular de radicalii liberi.
- Antioxidantii pot neutraliza radicalii liberi limitind distrugerea provocata,
daca suficienti antioxidanti sint involvati - Capacitate suficienta antioxidativa
- Acid Alfa Lipoic prin proprietati si functie regenereaza alti antioxidanti
ca: Vitamina C, Vitamina E, Glutation, Coenzima Q10 ofera protectie antioxidativa
de efectele radicalilor liberi.
Antioxidantii protejind celula de radicalii liberi - Capacitate suficienta
Sint o multime de antioxidanti in extracte de plante naturale, fitofarmaceutice, nutraceutice cu capacite de neutralizare a radicalilor liberi Antioxidanti cheie: Acid Alfa Lipoic, Coenzima Q10, Vitamine: Vitamina C, Vitamina E, Caretenoizi, (beta caroten,alfa caroten, licopen, luteina, zeaxantina) Compusi fenolici: Flavonoizi, polifenoli care confera protectie ridicata antoxidativa
- Suficienti antioxidanti de recomandat: Acid Alfa Lipoic, Ceai Verde EGCG, Vitamina C, Glutation, Vitamin E, Carotenoizi, Coenzima Q10 sau enzime antioxidante ca superoxid dismutaza (SOD) care detoxifica radicalul superoxid, peroxidul de hidrogen (H 2O2) si Glutation peroxidaza (GPx) care detoxifica peroxizii celulari
Spirulina contine
superoxid dismutaza (SOD) un antioxidant puternic 110000 Unitati/100g
Suficienti antioxidanti de recomandat: Acid alfa lipoic, Ceai Verde, Vitamina C, Glutation, Vitamin E, Carotenoizi, Coenzima Q10 sau enzime antioxidante ca superoxid dismutaza (SOD) care detoxifica radicalul superoxid, peroxidul de hidrogen (H2O2) si Glutation peroxidaza (GPx) care detoxifica peroxizii celulari
EGCG cu capacitate de absorbtie a radicalului liber a oxigenului - ORAC, comparatia valorilor fata de Vitamina C
38
Vitamina
D3 - 800 UI/zi si Calciu 1800 mg/zi cu potential in preventia de cancer mamar
si cancer de colon
39 Vitamina
D3 1000 UI mediaza transcrierea genei prin receptorul Vitamina D (VDR) si
transfoma celulele epiteliale de Cancer mamar in celule normale
40 Vitamina
D3 un modulator in cresterea de cancer mamar
41 Vitamina
D3 in preventia
de cancer mamar
42 Vitamina
D3 regleaza receptorul Vitamina D (VDR) care inhiba linia celulara HT29 si
MCF-7 la cancerul mamar si cancerul
de colon
43 Vitamina
D3 si Melatonina cresteTGF-beta-1 si induce inhibarea de cancer mamar
44 Suplimente
nutritionale de Vitamina D in preventia de cancer mamar la femei in menopauza
45 Vitamina
D3 1000 UI mediaza la regresia la tumora
46 Vitamina
D atenueaza cresterea de tumora retinoblastoma tumorala cu inducerea apoptozei
celulare de cancer
47 Vitamina
D in preventia de cancer de prostata
Terapia Anti-Aging:
Anti-Aging-Systeme
- Terapia Anti-Aging
Bibliografie-Referinte: ANTICANCER-ONCOXIN
Informatii din bibliografia electronica la tema: Nutritie si sanatate
1 Suzuki F, Brutkiewicz RR, Pollard RB. Importance
ot T-cells and macrophages in the antitumor activity of carboxyethylgermanium
sesquioxide (Ge-132). Anticancer Research 1985;5(5):479-483.
2 Aso H, Suzuki F, Yamaguchi T, Hayashi Y, Ebina T, Ishida N. Induction
of interferon and activation of NK cells and macrophages in mice by oral administration
of Ge-132, an organic germanium compound. Microbiology and Immunology 1985;29(1):65-74
3 Jang JJ, Cho KJ, Lee YS, Bae JH. Modifying responses of allyl sulfide, indole-3-carbinol
and germanium in a rat multi-organ carcinogenesis model. Carcinogenesis 1991;4:691-695.
4 Aso H, Suzuki F, Ebina T, Ishida N. Antiviral
activity of carboxyethylgermanium sesquioxide (Ge-132) in mice infected with
influenza virus. Department of Bacteriology, Tohoku University School of
Medicine, Sendai, Japan. J Biol Response Mod. 1989
Apr;8(2):180-9.
5 Mainwaring MG, Poor C, Zander DS, Harman E. Complete
remission of pulmonary spindle cell carcinoma after treatment with oral germanium
sesquioxide. Department of Medicine, Divisions of Hematology and Oncology,
University of Florida College of Medicine and Veterinary Affairs Medical Center,
Gainesville, FL 32610, USA. Chest. 2000 Feb;117(2):591-3.
6 Long QC, Zeng GX, Zhao XL. Pharmacokinetics
of germanium after po beta-carboxyethylgermanium sesquioxide in 24 Chinese volunteers.
Department of Clinical Pharmacology, Sun Yat-Sen University of Medical Sciences,
Guangzhou, China. Zhongguo Yao Li Xue Bao. 1996 Sep;17(5):415-8
7 Brutkiewicz RR, Suzuki F. Biological
activities and antitumor mechanism of an immunopotentiating organogermanium compound,
Ge-132 (review). Department of Internal Medicine, University of Texas Medical
Branch, Galveston 77550. In Vivo. 1987 Jul-Aug;1(4):189-203.
8 Suzuki F. Suppression
of tumor growth by peritoneal macrophages isolated from mice treated with carboxyethylgermanium
sesquioxide (Ge-132) Gan To Kagaku Ryoho. 1985 Nov;12(11):2122-8.
9 Suzuki F. Antitumor
activity of Ge-132, a new organogermanium compound, in mice is expressed through
the functions of macrophages and T lymphocytes Gan To Kagaku Ryoho. 1985
Jul;12(7):1445-52.
10 Suzuki F, Brutkiewicz RR, Pollard RB. Cooperation
of lymphokine(s) and macrophages in expression of antitumor activity of carboxyethylgermanium
sesquioxide (Ge-132). Anticancer Res. 1986 Mar-Apr;6(2):177-82.
11 Suzuki
F. Suppression of tumor growth by peritoneal macrophages isolated from mice treated
with carboxyethylgermanium
sesquioxide (Ge-132) Gan To Kagaku Ryoho. 1985 Nov;12(11):2122-8.
12 Sato I, Yuan BD, Nishimura T, Tanaka N. Inhibition of tumor growth and metastasis
in association with modification of immune response by novel organic germanium
compounds. Journal of Biological Response Modifiers 1985;4(2):159-168.
13 Kumano N, Ishikawa T, Koinumaru S, Kikumoto T, Suzuki S, Nakai Y, Konno K.
Antitumor effect of the organogermanium compound Ge-132 on the Lewis lung carcinoma
(3LL)
in C57BL/6 (B6) mice. Tohoku J Exp Med. 1985 May;146(1):97-104.
14 Sato I, Nishimura T, Kakimoto N, Suzuki H, Tanaka N. Prevention of pulmonary
metastasis of Lewis lung carcinoma and activation of murine macrophages by a
novel organic germanium compound, PCAGeS. Biological Response Modifiers 1988;7(1):1-5.
15 Tanaka N, Ohida J, Ono M, et al. Augmentation of NK activity in peripheral
blood lymphocytes of cancer patients by intermittent Ge-132 administration. Gan
To Kagaku Ryoho 1984;11(6):1303-1306.
16 Takeda
Y, Tominga T, Tei N, et al. Inhibitory effect of L-arginine on growth of rat
mammary tumors induced by 7,12-dimethlybenz(a)anthracine. Cancer Res 1975;35:2390-3.
17
Brittenden
J, Park KGM, Heys SD, et al. L-arginine stimulates host defenses in patients
with breast cancer. Surgery 1994;115:205-12.
18. Imler M, Ruscher H, Peter B et al: The effect of arginine in a case of recurrent
hepatic coma complicating a feminizing cortico-adrenal tumor with hepatic metastasis.
Sem Hop Paris 1973; 49:3183-3190.
19 Park KGM. The immunological and metabolic effects of L-arginine in human
cancer. Proc Nutr Soc 1993;52:387–401.
20 Cameron E, Pauling L. Supplemental
ascorbate in the supportive treatment of cancer: Prolongation of survival times
in terminal human cancer. Proc Natl Acad Sci U S A. 1976 Oct;73(10):3685-9.
21. Moreno JG, Miller MC, Gross S, et al. Circulating tumor cells predict survival
in patients with metastatic prostate cancer. Urology. 2005 Apr;65(4):713-8.
22. Budd GT, Cristofanilli M, Ellis MJ, et al. Circulating tumor cells versus
imaging--predicting overall survival in metastatic breast cancer. Clin Cancer
Res. 2006 Nov 1;12(21):6403-9.
23. Moertel CG, Fleming TR, Creagan ET, Rubin J,
O'Connell MJ, Ames MM. High-dose vitamin C versus placebo in the treatment of
patients with
advanced
cancer who
have had no prior chemotherapy. A randomized double-blind comparison. N Engl
J Med. 1985 Jan 17;312(3):137-41.
24 Imai
K, Suga K, Nagachi K. Cancer-preventive effects of drinking green
tea among a Japanese population. Prev Med. 1997;26(6):769-775.
- Mukhtar H., Ahmad N. Tea polyphenols: prevention of cancer and
optimizing health.
Am. J. Clin. Nutr.,
71: 1698S-702S, 2000.
- Cao Y., Cao R. Angiogenesis inhibited by drinking tea. Nature (Lond.), 398:
381 1999.
- Brown MD. Green tea (Camellia sinensis) extract and its possible role in the
prevention of cancer. Alt Med Rev. 1999;4(5):360-370.
- Sazuka M, et al. Inhibitory effects of green tea infusion on in vitro invasion
and in vivo metastasis of mouse lung carcinoma cells. Cancer Lett 1995;98:27-31.
25 Sugiyama
T, Sadzuka Y. Enhancing effects of green tea components on the antitumor activity
of adriamycin against M5076 ovarian sarcoma. Cancer letters 1998;133:19-26
- Fujiki H, Suganuma M, Okabe S, et al. Cancer inhibition by green tea. Mutation
Research. 1998;307-310.
- Gao Yt, McLaughlin JK, Blot WJ Reduced risk of esophageal cancer associated
with
green tea consumption. J Natl Cancer Inst. 1994 Jun 1;86(11):855-8.
- Hirose M. Inhibition of mammary gland carcinogenesis by green tea catechins.
Cancer Lett 1994;83:149-156.
- Inoue M, Tajima K, Mizutani M, et al. Regular consumption of green tea and
the risk of breast cancer recurrence: follow-up study from the Hospital-based
Epidemiologic Research Program at Aichi Cancer Center (HERPACC), Japan. Cancer
Lett. 2001;167(2):175-182.
- Kaegi E. Unconventional therapies for cancer: 2. Green tea. [Review]. The Task
Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.
CMAJ. 1998;158(8):1033-1035.
- Nakachi K, Suemasu K, Suga K, Takeo T, Imai K, Higashi Y. Influence of drinking
green tea on breast cancer malignancy among Japanese patients. Jpn J Cancer Res.
1998;89(3):254-261.
- Pianetti S, Guo S, Kavanagh KT, Sonenshein GE. Green tea polyphenol epigallocatechin-3
gallate inhibits Her-2/neu signaling, proliferation, and transformed phenotype
of breast cancer cells. Cancer Res. 2002;62(3):652-655.
- Setiawan VW, Zhang ZF, Yu GP, et al. Protective effect of green tea on the
risks of chronic gastritis and stomach cancer. Int J Cancer. 2001;92(4):600-604.
- Sano T, Sasako M. Green tea and gastric cancer. N Engl J Med. 2001;344(9):675-676.
- Tsubono Y, Nishino Y, Komatsu S, et al. Green tea and the risk of gastric cancer
in Japan. N Engl J Med. 2001;344(9):632-636.
- Yu GP, Hsieh CC, Wang LY, Yu SZ, Li XL, Jin TH. Green-tea consumption and risk
of stomach cancer: a population-based case-control study in Shanghai, China.
Cancer Causes Control. 1995;6(6):532-538.
- Sugiyama T, Sadzuka Y. Enhancing effects of green tea components on the antitumor
activity of adriamycin against M5076 ovarian sarcoma. Cancer Lett. 1998;133(1):19–26.
- Ji B-T, Chow W-H, Hsing AW, et al. Green tea consumption and the risk of pancreatic
and colorectal cancers. Int J Cancer. 1997;70:255-258.
- Fujiki H, Suganuma M, Okabe S, et al. Mechanistic findings of green tea as
cancer preventive for humans. Proc Soc Exp Biol Med. 1999;220(4):225–228.
- Ahmad N, Mukhtar H. Green tea polyphenols and cancer: biologic mechanisms and
practical implications. Nutr Rev. 1999; 57:78-83.
- Ahmad N, et al. Green tea constituent epigallocathechin-3-gallate and induction
of apoptosis and cell cycle arrest in human carcinoma cells. H Natl Cancer Inst
1997;89:1881-86.
- Wang Z, et al. Antimutagenic activity of green tea polyphenols. Mutation Research.
1989;223:273-285.
- Jankun J, et al. Why drinking green tea could prevent cancer. Nature 1997;387:561
- Taniguchi S, et al. Effect of (-)-epigallocatechin gallate, the main constituent
of green tea, on lung metastasis with mouse B16 melanoma cells lines. Cancer
Lett 1992;65:51-4.
-Kaegi E, on behalf of the Task Force on Alternative Therapies of the Canadian
Breast Cancer Research Initiative. Unconventional therapies for cancer: 2. Green
tea. Canadian Medical Association 1998;158:1033-1035.
26 Demeule
M, Brossard M, Pagé, M, et al. Matrix metalloproteinase inhibition
by green tea catechins. Biochim Biophys Acta. 2000; 1478:51-60.
27 Liao
S, Umekita Y, Guo J, Kokontis JM, Hiipakka RA. Growth inhibition
and regression of human prostate and breast tumors in athymic
mice by tea epigallocatechin gallate. Cancer Lett. 1995;96:239-243.
- Carlin BI, Pretlow TG, Pretlow TP, et al. Green tea polyphenols inhibit growth
of PC xenograft cwr-22 and decrease ornithine decarboxylase activity: implications
for PC chemoprevention. J Urol 155: 510A, 1996.
28 Hu
G, Han C, Chen J.Inhibition of oncogene expression by green
tea and (-)-epigallocatechin gallate in mice. Institute of Nutrition
and
Food Hygiene, Chinese Academy of Preventive Medicine, Beijing,
China. Nutr Cancer. 1995;24(2):203-9.
29 Carlin
BI, Pretlow TG, Pretlow TP, et al. Green tea polyphenols inhibit growth of
PC xenograft cwr-22 and decrease ornithine
decarboxylase activity: implications
for PC chemoprevention. J Urol 155: 510A, 1996.
30 Liao
S, Hipakka, RA. Selective inhibition of steroid 5-alfa-reductase [5AR] by tea
epicatechin-3-gallate and
epigallocatechin-3-gallate. Biochemical
and
Biophysical Research Communications; 214(3), 833-838,1995).
- Gupta S, Ahmad N, Mukhtar H. Prostate cancer chemoprevention by green tea.
Semin Urol Oncol. 1999; 17:70-76.
- Suganuma M, Okabe S, Sueoka N, et al. Green tea and cancer chemoprevention.
Mutation Res. 1999; 428:339-344.
- Suganuma M, Okabe S, Kai Y, et al. Synergistic effects of (-)-epigallocatechin
gallate with (-)-epicatechin, sulindac or tamoxifen on cancer-preventive
activity in the human lung cancer cell line PC-9. Cancer Research 1999; 59: 44-47.
31 Sachinidis
A, Seul C, Seewald S, et al. Green tea compounds inhibit tyrosine phosphorylation
of PDGF beta-receptor and transformation of A172 human glioblastoma.
FEBS Lett. 2000; 471:51-55.
32 Katiyar
SK, Matsui MS, Elmets CA, Mukhtar H. Polyphenolic antioxidant (-)-epigallocatechin-3-gallate
from green tea reduces UVB-induced inflammatory responses and infiltration
of leukocytes in human skin. Photochem Photobiol 1999;69:148-153.
- Mukhtar H., Katiyar S. K. et al. Green tea and skin: anticarcinogenic effects.
J. Investig. Dermatol. 102: 3-7,
33 Beckman,
K. & Ames, B. (1998) "The free radical theory of aging
matures" Physiol Rev 78: 548-81
34 Valcic
S, Muders A, Jacobsen NE, Liebler DC, Timmermann BN. Antioxidant chemistry
of green tea catechins. Identification of products of the reaction of (-)-epigallocatechin
gallate with peroxyl radicals. Department of Pharmacology & Toxicology,
College of Pharmacy, The University of Arizona, Tucson, Arizona 85721, USA.
Chem Res
Toxicol. 1999 Apr;12(4):382-6.
35 Luo
M, Kannar K, Wahlqvist ML, O'Brien RC. Inhibition of LDL oxidation by green
tea extract. Lancet. 1997 Feb 1;349(9048):360-361.
- Miura Y, Chiba T, Miura S, et al. Green tea polyphenols (flavan 3-ols) prevent
oxidative modification of low density lipoproteins: an ex vivo study in humans.
J Nutr Biochem. 2000; 11:216-222.
- Yang TTC, Koo MWL. Inhibitory effect of Chinese green tea on endothelial
cell-induced LDL oxidation. Atherosclerosis. 2000; 148:67-73.
- Shi X, Ye J, Leonard SS, et al. Antioxidant properties of epicatechin gallate
(ECG) and its inhibition of Cr (VI)-induced DNA damage and Cr (IV)- or TPA-stimulated
NF-Kappa B activation. Mol Cell Biochem. 2000; 206:125-132.
- Ketsawatsakul U., Whiteman M., Halliwell B. A reevaluation of the peroxynitrite
scavenging activity of some dietary phenolics. Biochem. Biophys. Res. Commun.,
279: 692-699, 2000.
- Nakagawa K, Ninomiya M, Okubo T, Aoi N, Juneja LR, Kim M, Yamanaka K, Miyazawa
T. Tea catechin supplementation increases antioxidant capacity and prevents
phospholipid hydroperoxidation in plasma of humans. Laboratory of Biodynamic
Chemistry, Tohoku
University Graduate School of Life Science and Agriculture, Sendai 981-8555,
Japan. J Agric Food Chem. 1999 Oct;47(10):3967-73.
- Wei H, Zhang X, Zhao JF, Wang ZY, Bickers D, Lebwohl M. Scavenging of hydrogen
peroxide and inhibition of ultraviolet light-induced oxidative DNA damage by
aqueous extracts from green tea. Free Radic Biol Med. 1999;26(11-12):1427-1435.
- Miyazawa T.Absorption, metabolism and antioxidative effects of tea catechin
in humans. Biodynamics Chemistry, Lab., Tohoku University Graduate School
of Life Science & Agriculture, Sendai, Japan. Biofactors. 2000;13(1-4):55-9.
- Yang TTC, Koo MWI. Chinese green tea lowers cholesterol level through an
increase in fecal lipid excreiton. Life Sciences. 1999:66:5:411-423.
- M.K. Shigenaga and B.N. Ames. Free Radical Biology and Medicine 10:211-6,1991.
36 Shigenaga
MK, Ames BN. Assays for 8-hydroxy-2'-deoxyguanosine, a biomarker of in vivo
oxidative DNA damage. Free Radic. Biol. Med., 1991; 10: 211-6.
- H. Kasai, P.F. Crain, Y. Kuchino, S. Nishimura, A.Ootsuyama and H. Tanooka.
Carcinogenesis 7:1849-51, 1986.
37 Guyton
KZ, Kensler TW, Posner GH. Vitamin D and vitamin D analogs as cancer chemopreventive
agents. CCS Associates, 2005 Landings Drive, Mountain View, CA
94043, USA. Nutr
Rev. 2003 Jul;61(7):227-38.
38 Garland
CF, Garland FC, Gorham ED. Calcium and vitamin D. Their potential roles in
colon and breast cancer prevention. Department of Family and Preventive
Medicine, University of California, San Diego 92093, USA. Ann N Y Acad
Sci. 1999;889:107-19.
39 Wietzke
JA, Ward EC, Schneider J, Welsh J. Regulation of the human vitamin D3
receptor promoter in breast cancer cells is mediated through Sp1 sites. Department
of Biological Sciences, University of Notre Dame, 214 Galvin Life Science Building,
Notre Dame, IN 46556, USA. Mol Cell Endocrinol. 2005 Jan 31;230(1-2):59-68.
40 Welsh
J, Wietzke JA, Zinser GM, Smyczek S, Romu S, Tribble E, Welsh JC, Byrne B,
Narvaez CJ. Impact of the Vitamin D3 receptor on growth-regulatory pathways
in mammary gland and breast cancer. Department of Biological Sciences, University
of Notre Dame, Notre Dame, IN 46556, USA. J Steroid Biochem Mol Biol. 2002
Dec;83(1-5):85-92.
41 Welsh
J, Wietzke JA, Zinser GM, Byrne B, Smith K, Narvaez CJ. Vitamin D-3 receptor
as a target for breast cancer prevention. Department of
Biological
Sciences,
University of Notre Dame, Notre Dame, IN 46556, USA. J Nutr. 2003 Jul;133(7
Suppl):2425S-2433S.
42 Gilad
LA, Bresler T, Gnainsky J, Smirnoff P, Schwartz B. Regulation of vitamin D
receptor expression via estrogen-induced activation of the ERK
1/2 signaling
pathway in colon and breast cancer cells. Institute of Biochemistry, Food
Science and Nutrition, Faculty of Agricultural, Food and Environmental Quality
Sciences,
The Hebrew University of Jerusalem,
P.O. Box 12, Rehovot 76100, Israel. J Endocrinol. 2005 Jun;185(3):577-92.
43 M
. Bizzarri Melatonin and vitamin D3 increase TGF-ß1 release and induce
growth inhibition in breast cancer cell cultures . Journal of Surgical Research
, Volume 110 , Issue 2 , Pages 332 - 337
44 McCullough
ML, Rodriguez C, Diver WR, Feigelson HS, Stevens VL, Thun MJ, Calle EE. Dairy,
calcium, and vitamin
D intake and postmenopausal
breast
cancer risk in the Cancer Prevention Study II Nutrition Cohort.
Epidemiology and Surveillance Research, American Cancer Society, 1599 Clifton
Road Northeast, Atlanta, GA 30329-4251, USA. Cancer Epidemiol Biomarkers
Prev.
2005 Dec;14(12):2898-904.
45 W
Alton Jones Cell Science Center Lake Placid NY Vitamin D3 Mediated Tumor
Regression Kathryn Van Weelden; Annual rept. 1 Jul 97-30 Jun 98
46 Audo
I, Darjatmoko SR, Schlamp CL, Lokken JM, Lindstrom MJ, Albert DM, Nickells
RW. Vitamin D analogues increase p53, p21, and apoptosis
in a xenograft model
of human retinoblastoma. Department of Ophthalmology, University of
Wisconsin-Madison Medical School, Madison, WI 53706, USA. Invest Ophthalmol
Vis Sci. 2003 Oct;44(10):4192-9.
47 Tuohimaa
P, Lyakhovich A, Aksenov N, Pennanen P, Syvälä H, Lou
YR,
Ahonen M, Hasan T, Pasanen P, Bläuer M, Manninen T, Miettinen S, Vilja
P, Ylikomi T. Vitamin D and prostate cancer. Medical School, University of
Tampere,
33014, Tampere, Finland. J Steroid Biochem Mol Biol. 2001 Jan-Mar;76(1-5):125-34.
Parerea din pasajele acestui site nu a fost independent cercetate sau confirmate.
|
Anti-Aging-Systeme
© 2008
|
Design by NB |